Merck gets dueling analyst calls after vaccine data rally
Merck draws mixed analyst action after promising cancer vaccine results lifted shares almost 13% yesterday, with RBC Capital Markets downgrading to hold and Morgan Stanley upgrading to buy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.